全球智能注射器市场 – 行业趋势及 2029 年预测

市场分析和规模

智能注射器具有内置灭活机制等功能，可保护人们免受针刺伤害、血液传播感染（如乙肝和丙肝）以及人类免疫缺陷病毒 (HIV)。疫苗接种、药物输送和血液采集只是它们可以处理的少数应用。根据应用的不同，可以使用多种类型的智能注射器，例如自动禁用 (AD) 注射器、被动安全注射器和主动安全注射器。

Data Bridge Market Research 分析，智能注射器市场规模在 2021 年为 85.1058 亿美元，到 2029 年将飙升至 200.4105 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 11.30%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

Smart syringes are medical equipment with built-in safety features that prevent syringe reuse and regulate dangerous injection techniques. They have features that reduce needlestick injuries and the transmission of blood-borne infections like hepatitis C virus (HCV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV) in those who use them (HIV).

Smart Syringes Market Dynamics

Drivers

• Increasing prevalence of numerous target diseases

The prevalence of such diseases has increased, vaccination programmes against the target disease have increased dramatically in various regions of the world. Moreover, the need to reduce hospital-acquired infections will drive demand for smart syringes throughout the projection period. Smart syringes are in high demand because to the ever-increasing elderly population around the world.

• Rise in need for safety syringes in emerging economies

The emerging countries of Asia-Pacific and Latin America are promising markets for smart syringes. The use of traditional syringes has been slowed due to an increase in needle stick injuries and a rise in HIV and hepatitis transmission rates. Furthermore, due to the growing demand for safer injection procedures, the adoption rate of smart syringes is rapidly increasing.

• Increase in prevalence of chronic disease

The rise in needle stick injuries has had a significant impact on the market for smart syringes. Because needlestick injuries are the major cause of blood-borne infections among healthcare personnel, the impact of this factor is expected to grow during the projected period. Human Immunodeficiency Virus (HIV), hepatitis B, and hepatitis C can all be transmitted through these injuries. Other infections that can be transmitted through needle stick injuries include blastomycosis, brucellosis, cryptococcosis, diphtheria, cutaneous gonorrhoea, herpes, malaria, mycobacteriosis, sporotrichosis, syphilis, and tuberculosis. In 2019, SERMO (a major medical solutions firm) conducted a survey in the United Kingdom on needle stick injuries.

Opportunities

The market is growing due to an increase in the number of needle stick injuries, a high frequency of blood-borne transmission of diseases such hepatitis B, C, and HIV from inappropriate injection practises, a rise in the use of safety syringes, and technological improvements. Furthermore, the WHO's mandated recommendations to convert to smart syringes, assuring safe injection procedures, is a major element driving market growth.

Restraints/Challenges

• High cost and unaffordability of safety syringes

Smart syringes are more expensive than regular syringes, which makes them difficult to implement globally. Some variants are comparable in price to single-use syringes. Others, on the other hand, can cost up to five times as much as others, depending on the technical sophistication of the safety systems, making them prohibitively expensive in some low- and middle-income nations.

Furthermore, the significant capital investment necessary to produce and maintain a few safety syringes, as well as cost changes based on technologically upgraded syringes, hinder market expansion. The impact of this aspect is predicted to decrease during the analysis period due to continual technical developments and a rise in the number of smart syringes firms.

This smart syringes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the smart syringes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Smart Syringes Market

Due to pre-planned COVID-19 immunisation initiatives around the world, the volume of smart syringes to be used in the next years is predicted to skyrocket. Within the first days of the pandemic, the COVID-19 infection demonstrated its ability to cause medical equipment shortages, such as gowns, face masks, and personal protective equipment (PPE). As a result, governments and organisations have already begun syringe manufacturing and production to address such supply chain challenges, as syringes are a critical component of vaccination distribution. This global demand for new coronavirus vaccination is well prepared to drive smart syringe production throughout the pandemic phase.

Global Smart Syringes Market Scope

The smart syringes market is segmented on the basis of product, application, age group and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

PRODUCT

• Auto-disable syringes
• Active safety syringes
• Passive safety syringes

APPLICATION

• Drug delivery
• Vaccination
• Blood specimen collection

AGE GROUP

• Pediatrics
• Adults

END-USER

• Hospitals and HMOs
• Diabetic patients
• Family practices (Physicians)
• Psychiatrics
• Others

Smart Syringes Market Regional Analysis/Insights

The smart syringes market is analysed and market size insights and trends are provided by country, product, application, age group and end-user as referenced above.

The countries covered in the smart syringes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominating the global smart syringe market due to the growing awareness regarding the various issues associated with traditional needles like needlestick injury cases.

Asia-Pacific is expected to witness huge growth during the forecast period due to the fast proliferation of the medical and healthcare sector in the region. Furthermore, government authorities' growing investments in order to develop the region's healthcare infrastructure will accelerate the regional market's growth during the forecast period of 2022 to 2029.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Smart Syringes Market Share Analysis

智能注射器市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对智能注射器市场的关注有关。

智能注射器市场的一些主要参与者包括：

• 百特（美国）
• 泰尔茂株式会社 (日本)
• B. Braun Melsungen Ag（德国）
• 康德乐 (美国)
• BD（美国）
• 派克汉尼汾公司 (美国)
• Gerresheimer AG（德国）
• Numedico Technologies Pty Ltd（澳大利亚）
• AdvaCare Pharma（美国）
• Retractable Technologies, Inc.（美国）
• MERIT MEDICAL SYSTEMS（美国）
• NIPRO（日本）
• REVOLUTIONS MEDICAL CORPORATION（美国）
• 史密斯集团有限公司（英国）
• 托马斯科学公司 (美国)
• McKesson Medical-Surgical Inc.（美国）

SKU-68626